H Edward Fleming's Insider Trades & SAST Disclosures

H Edward Fleming's most recent trade in Upstream Bio Inc. was a trade of 17,096 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 10, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Upstream Bio Inc.
Fleming H. Edward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2024 17,096 17,096 - - Stock Option (Right to Buy)
CRISPR Therapeutics AG
H. Edward Fleming Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 13,000 13,000 - - Stock Option (Right to Buy)
CRISPR Therapeutics AG
H Edward Fleming Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 12,000 12,000 - - Stock Option (Right to Buy)
CRISPR Therapeutics AG
H Edward Fleming Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades